RxDoctor Payments Data

Serena Macdonald, MD

Family Medicine · Wilson, NCNPI 1043717432

Payments from drug & device makers

$530in general payments, 2019–2025

Across 18 payments — averaging $29.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$153
  • GSK$110
  • AbbVie$98
  • Avadel CNS Pharmaceuticals, LLC$76
  • Abbott$42
  • Boehringer Ingelheim$18
  • plus $34 from 2 others

What the payments were for

  • Food & beverage$530100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$530 in reported general payments places this provider in the 60th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$103,621
Medicare patients
190
Services billed
2,533

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide161$167,470
JardianceEmpagliflozin83$96,610
EliquisApixaban53$49,010
TrulicityDulaglutide44$43,444
TradjentaLinagliptin39$42,347
MounjaroTirzepatide34$39,672
LinzessLinaclotide29$34,272
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$32,946
JanuviaSitagliptin Phosphate32$26,638
RybelsusSemaglutide22$22,928
XareltoRivaroxaban31$22,797
RexultiBrexpiprazole13$19,193
EntrestoSacubitril/Valsartan15$15,462
JanumetSitagliptin Phos/Metformin Hcl17$12,891
MyrbetriqMirabegron16$12,584

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$153$190,398183 claims
Boehringer IngelheimJardiance, Tradjenta$18$138,957122 claims
GSKTrelegy Ellipta, Breo Ellipta$110$39,71852 claims
AbbVieLinzess$98$34,27229 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Wilson

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →